Supply Chain

The rising cost of specialty drugs is the number one driver of healthcare expenses for large employers, according to a survey released Tuesday by the National Business Group on Health.

Ninety percent savings on generic drug costs? It sounds too good to be true — but that's what brothers Geoffrey and Matthew Chaiken are promising with their new technology company Blink Health.

Britain-based AstraZeneca's experimental drug selumetinib failed to show positive results in a late-stage clinical trial for lung cancer, according to Reuters.

There is a large online market for the unauthorized sale of previously used continuous positive airway pressure devices to treat obstructive sleep apnea, according to a recent study published in JAMA Internal Medicine.

The Food and Drug Administration recently approved the CyPass Micro-Stent for the treatment of glaucoma.

Global sourcing for hospitals and IDNs step 4: customization and continued product expansion.

In a recent press release, Medline, the nation's largest privately held manufacturer and distributor of medical supplies and clinical solutions, today announced its purchase of 51 acres of land for a new distribution center in Auburndale.

Canada-based Valeant Pharmaceuticals today entered into a licensing agreement with Norgine for the drug NER1006.

The Food and Drug Administration granted emergency use authorization for a multiplex nucleic acid test to detect Zika virus.

Mundelein, Ill.-based Medline will build a new distribution center in Auburndale, Fla.